1 – 60 of 60
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
(
- Contribution to journal › Article
-
Mark
The fetal thymus has a unique genomic copy number profile resulting from physiological T cell receptor gene rearrangement
(
- Contribution to journal › Article
- 2015
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
-
Mark
Drug Compound Characterization by Mass Spectrometry Imaging in Cancer Tissue
(
- Contribution to journal › Scientific review
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
(
- Contribution to journal › Article
- 2014
-
Mark
Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
(
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated tn antigen.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article
- 2012
-
Mark
Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.
(
- Contribution to journal › Article
- 2010
-
Mark
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
(
- Contribution to journal › Article
- 2009
-
Mark
Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.
(
- Contribution to journal › Article
- 2007
-
Mark
In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra.
(
- Contribution to journal › Article
-
Mark
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
(
- Contribution to journal › Article
-
Mark
Regression analysis and modelling of data acquisition for SELDI-TOF mass spectrometry.
(
- Contribution to journal › Article
- 2004
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
(
- Contribution to journal › Article
- 2003
-
Mark
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
-
Mark
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas
(
- Contribution to journal › Article
- 2002
-
Mark
Cytogenetic aberrations and their prognostic impact in chondrosarcoma
(
- Contribution to journal › Article
-
Mark
DNA ploidy in soft tissue sarcoma: Comparison of flow and image cytometry with clinical follow-up in 93 patients : comparison of flow and image cytometry with clinical follow-up in 93 patients
(
- Contribution to journal › Article
-
Mark
Predominance of CIN versus MSI in the development of rectal cancer at young age.
(
- Contribution to journal › Article
-
Mark
Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.
(
- Contribution to journal › Article
- 2001
-
Mark
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer
(
- Contribution to journal › Article
- 2000
-
Mark
Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation
(
- Contribution to journal › Article
- 1999
-
Mark
Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
(
- Contribution to journal › Article
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas : prognostic implications
(
- Contribution to journal › Article
- 1998
-
Mark
p53-dependent and -independent differentiation of leukemic U-937 cells : relationship to cell cycle control
(
- Contribution to journal › Article
-
Mark
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
(
- Contribution to journal › Article
- 1997
-
Mark
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients
(
- Contribution to journal › Article
-
Mark
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation
(
- Contribution to journal › Article
- 1996
-
Mark
Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25-dihydroxycholecalciferol in leukemic U-937 cells
(
- Contribution to journal › Article
-
Mark
Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis
(
- Contribution to journal › Article
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
- 1995
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
(
- Contribution to journal › Article
- 1994
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
(
- Contribution to journal › Article
-
Mark
Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique
(
- Contribution to journal › Article
-
Mark
An improved mathematical method to estimate DNA synthesis time of bromodeoxyuridine-labelled cells, using FCM-derived data
(
- Contribution to journal › Article
- 1993
-
Mark
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors
(
- Contribution to journal › Article
-
Mark
Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content
(
- Contribution to journal › Article
-
Mark
Cytogenetic findings in 33 osteosarcomas
(
- Contribution to journal › Article
-
Mark
Growth interaction between different tumor populations in human endometrial adenocarcinoma growing in nude mice
(
- Contribution to journal › Article
-
Mark
Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice
(
- Contribution to journal › Article
- 1992
-
Mark
Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content
(
- Contribution to journal › Article
-
Mark
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts
(
- Contribution to journal › Article
-
Mark
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
(
- Contribution to journal › Article
- 1991
-
Mark
Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma
(
- Contribution to journal › Article
-
Mark
DNA ploidy assessment of breast milk (colostrum) in primiparous women of different ages
(
- Contribution to journal › Article
- 1990
-
Mark
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA ploidy analysis of soft tissue sarcomas. A comparative study of preoperative fine needle aspirates and postoperative fresh tissues and archival material
(
- Contribution to journal › Article
-
Mark
Prognostic indicators in node-negative breast cancer (Reply)
(
- Contribution to journal › Letter